Download our 2022 Q1 Quarterly Drug Pipeline Report
Our report is broken into four sections to help your team:
- Generic Launch
- Specialty and Traditional
- New-drug Indication
- Comments & Insights Section
The Generic Launch section details which branded drugs will be released as first-time generics, their estimated date of release or loss of exclusivity, and the number of manufacturers competing for the generic alternatives. We also provide financial data that shows the 2020 sales for the brand drugs.
The information provided is for informational purposes only and should not be solely relied upon for decision-making purposes.